Drugs & Diseases > Medscape > Fast Five Quizzes
Fast Five Quiz: Myelodysplastic Syndrome Presentation and Diagnosis
Emmanuel C. Besa, MD
Myelodysplastic syndrome (MDS) is a group of related disorders that arise as the result of distorted hematopoietic stem cell function, inflammatory and innate immune deregulation, and multiple genomic events. These molecular alterations increase the risk of infections, bleeding, and potentially, progression to acute myeloid leukemia (AML). The disease course involves a series of cytogenetic events, making the condition a heterogeneous one. MDS may involve one, two, or three myeloid hematopoiesis cell lineages — erythrocytic, granulocytic, and/or megakaryocytic — depending on the subtype and stage of the disease.
Would you be able to identify one of these heterogeneous disorders? Test your knowledge with this quick quiz.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Emmanuel C. Besa. Fast Five Quiz: Myelodysplastic Syndrome Presentation and Diagnosis - Medscape - May 12, 2021.
Authors and Disclosures
Professor Emeritus, Department of Medicine, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Sidney Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
Disclosure: Emmanuel C. Besa, MD, has disclosed no relevant financial relationships.
Related Conditions & Diseases
Myelodysplastic Syndromes Staging
Pathology of Unclassifiable Myelodysplastic Syndromes (MDS-U)
Myelodysplastic Syndrome (MDS)
Pediatric Myelodysplastic Syndrome
Pathology of Myelodysplastic Syndrome with Multilineage Dysplasia
Pathology of Myelodysplastic Syndrome With Single Lineage Dysplasia (MDS-SLD)
Pediatric Myelodysplastic Syndromes Pathology
Latest News & Perspective
Ospemifene and HT Boost Vaginal Microbiome in Vulvovaginal Atrophy
Change Makers: Dr Valerie Montgomery Rice on Healthcare Disparities and Moving From Talk to Action
More Guidance Needed for Cancer Screening in Rheumatology Patients
Myelodysplastic Syndromes: Classification, Features, Diagnosis, and Treatment Options
Myelodysplastic Syndrome and Myeloproliferative Neoplasms 1.0 CME / CE / ABIM MOC Credits
Myelodysplastic Syndrome and Myeloproliferative Neoplasms
Geron Says Blood Cancer Drug Succeeds in Late-Stage Study, Shares Surge News
b:curatedcuratedHasData : false